Stay updated on Tagraxofusp in CD123+ AML Clinical Trial
Sign up to get notified when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.

Latest updates to the Tagraxofusp in CD123+ AML Clinical Trial page
- Check3 days agoChange DetectedThe record history now includes a new revision entry: v3.6.2, replacing the previous v3.6.0 entry. This marks an updated version of the study record without changing its substantive details.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedEnrollment status changed to closed, indicating the study is no longer seeking participants. The record version was updated to Revision: v3.6.0, replacing the previous v3.5.5.SummaryDifference0.7%

- Check24 days agoChange DetectedThe record history shows a new revision label v3.5.5, indicating an administrative page version update. The update does not modify the study data or visible content beyond versioning.SummaryDifference0.1%

- Check45 days agoChange DetectedThe change set adds a new revision entry, v3.5.4, and removes the prior revision, v3.5.3, from the study record history. This reflects an update to the page's revision history rather than a change to the study data.SummaryDifference0.1%

- Check67 days agoChange DetectedA site release/version update is reflected on the page (moving from one revision identifier to the next) without indicating any change to the trial record itself.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Tagraxofusp in CD123+ AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.